Cargando…
Congenital coagulation factor V deficiency with intracranial hemorrhage
BACKGROUND: Congenital coagulation factor V (FV) deficiency is a very rare hemorrhagic disease with an incidence of approximately one in a million. The common clinical manifestations of FV deficiency include ecchymosis and mucosal bleeding. Life‐threatening intracranial bleeding is rare. It has been...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701843/ https://www.ncbi.nlm.nih.gov/pubmed/36125894 http://dx.doi.org/10.1002/jcla.24705 |
_version_ | 1784839629903495168 |
---|---|
author | Yang, Jingjing Mao, Hongli Sun, Li |
author_facet | Yang, Jingjing Mao, Hongli Sun, Li |
author_sort | Yang, Jingjing |
collection | PubMed |
description | BACKGROUND: Congenital coagulation factor V (FV) deficiency is a very rare hemorrhagic disease with an incidence of approximately one in a million. The common clinical manifestations of FV deficiency include ecchymosis and mucosal bleeding. Life‐threatening intracranial bleeding is rare. It has been reported in several cases. However, the molecular basis has been established in only a few cases. METHODS: We reported a 2‐month‐old girl with congenital FV deficiency and intracranial hemorrhage. Coagulation screening combined with clinical manifestations was performed to diagnose congenital FV deficiency. Genetic testing was performed to identify the pathogenic genes. A literature review was included to emphasize the clinical manifestation, diagnosis, and treatment for congenital FV deficiency with intracranial bleeding. RESULTS: The coagulation tests revealed a significantly prolonged prothrombin time (PT) of 51 s and an activated partial thromboplastin time (APTT) of 73.7 s. The patient had a plasma FV activity of 0.9%. Genetic testing showed compound heterozygous mutations of the patient's FV gene. A literature review showed that patients with homozygous or compound heterozygous variants of the FV gene were often associated with a severe bleeding phenotype. CONCLUSION: Our study provides a direction for the rapid and accurate diagnosis and treatment for FV deficiency to avoid life‐threatening bleeding. Infants with spontaneous cranial hematoma and intracranial hemorrhage should be investigated for underlying hemostatic defects. Congenital coagulation factor deficiency should be considered. Once congenital FV deficiency is diagnosed, fresh frozen plasma (FFP) should be given on a regular basis. Liver transplantation may be performed in severe cases. |
format | Online Article Text |
id | pubmed-9701843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97018432022-11-28 Congenital coagulation factor V deficiency with intracranial hemorrhage Yang, Jingjing Mao, Hongli Sun, Li J Clin Lab Anal Research Articles BACKGROUND: Congenital coagulation factor V (FV) deficiency is a very rare hemorrhagic disease with an incidence of approximately one in a million. The common clinical manifestations of FV deficiency include ecchymosis and mucosal bleeding. Life‐threatening intracranial bleeding is rare. It has been reported in several cases. However, the molecular basis has been established in only a few cases. METHODS: We reported a 2‐month‐old girl with congenital FV deficiency and intracranial hemorrhage. Coagulation screening combined with clinical manifestations was performed to diagnose congenital FV deficiency. Genetic testing was performed to identify the pathogenic genes. A literature review was included to emphasize the clinical manifestation, diagnosis, and treatment for congenital FV deficiency with intracranial bleeding. RESULTS: The coagulation tests revealed a significantly prolonged prothrombin time (PT) of 51 s and an activated partial thromboplastin time (APTT) of 73.7 s. The patient had a plasma FV activity of 0.9%. Genetic testing showed compound heterozygous mutations of the patient's FV gene. A literature review showed that patients with homozygous or compound heterozygous variants of the FV gene were often associated with a severe bleeding phenotype. CONCLUSION: Our study provides a direction for the rapid and accurate diagnosis and treatment for FV deficiency to avoid life‐threatening bleeding. Infants with spontaneous cranial hematoma and intracranial hemorrhage should be investigated for underlying hemostatic defects. Congenital coagulation factor deficiency should be considered. Once congenital FV deficiency is diagnosed, fresh frozen plasma (FFP) should be given on a regular basis. Liver transplantation may be performed in severe cases. John Wiley and Sons Inc. 2022-09-20 /pmc/articles/PMC9701843/ /pubmed/36125894 http://dx.doi.org/10.1002/jcla.24705 Text en © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Yang, Jingjing Mao, Hongli Sun, Li Congenital coagulation factor V deficiency with intracranial hemorrhage |
title | Congenital coagulation factor V deficiency with intracranial hemorrhage |
title_full | Congenital coagulation factor V deficiency with intracranial hemorrhage |
title_fullStr | Congenital coagulation factor V deficiency with intracranial hemorrhage |
title_full_unstemmed | Congenital coagulation factor V deficiency with intracranial hemorrhage |
title_short | Congenital coagulation factor V deficiency with intracranial hemorrhage |
title_sort | congenital coagulation factor v deficiency with intracranial hemorrhage |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701843/ https://www.ncbi.nlm.nih.gov/pubmed/36125894 http://dx.doi.org/10.1002/jcla.24705 |
work_keys_str_mv | AT yangjingjing congenitalcoagulationfactorvdeficiencywithintracranialhemorrhage AT maohongli congenitalcoagulationfactorvdeficiencywithintracranialhemorrhage AT sunli congenitalcoagulationfactorvdeficiencywithintracranialhemorrhage |